Medicine Shoppe International, Incorporated v. Mohammed Siddiqui

549 F. App'x 131
CourtCourt of Appeals for the Fourth Circuit
DecidedNovember 5, 2013
Docket12-2001
StatusUnpublished
Cited by3 cases

This text of 549 F. App'x 131 (Medicine Shoppe International, Incorporated v. Mohammed Siddiqui) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Medicine Shoppe International, Incorporated v. Mohammed Siddiqui, 549 F. App'x 131 (4th Cir. 2013).

Opinion

Vacated and remanded by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit.

PER CURIAM.

Medicine Shoppe International, Inc. (“MSI”) appeals the district court’s order granting summary judgment in favor of Appellees finding that the parties entered *132 into a binding and effective settlement agreement that disposed of the case. For the following reasons, we vacate and remand.

I.

MSI is a national franchisor that grants licenses to franchisees to operate prescription pharmacies known as the “Medicine Shoppe System.” In exchange for the franchise, MSI receives license fees from its licensees based on a percentage of each pharmacy’s monthly gross receipts. Ap-pellees, Mohammed A. Siddiqui, Loch Raven Pharmacy Inc., and Belvedere Enterprises Inc., purchased two Medicine Shoppe Pharmacies from a former franchisee, Anwar Yousuf and his corporations, Drugsmart, Inc. (“Drugsmart”) and Drugsmart Enterprises, Inc. (“Drugsmart Enterprises”). Yousuf and Noreen Anwar were the only shareholders of Drugsmart and Drugsmart Enterprises.

On February 25, 2001, Drugsmart and MSI entered into a licensing agreement. Drugsmart agreed to operate a Medicine Shoppe Pharmacy located at 6307 York Road in Baltimore, Maryland. On May 20, 2003, Drugsmart and MSI entered into a second licensing agreement, and Drugs-mart agreed to operate a second Medicine Shoppe Pharmacy located at 1724 E. Northern Parkway in Baltimore, Maryland. In exchange for the licenses to operate the pharmacies, MSI obtained a security interest in Drugsmart’s prescription files.

On or about May 2004, Yousuf incorporated Drugsmart Enterprises. Drugsmart Enterprises began operating the Parkway Medicine Shoppe, and on October 14, 2004, MSI entered into a security agreement with Drugsmart Enterprises. Under the security agreement, MSI extended Drugs-mart Enterprises a $160,000 line of credit. In exchange, MSI received a security interest in the Parkway Medicine Shoppe’s equipment, fixtures, inventory, accounts receivable, prescription files, customer lists, and goodwill.

By March 1, 2010, the two pharmacies owed a substantial sum of money to MSI. MSI terminated the franchise agreements and gave the franchisees until March 31, 2010 to satisfy their outstanding obligations, de-identify, and close the stores. On March 30, 2010, Yousuf notified MSI that he intended to transfer the pharmacies to Siddiqui. Then, Yousuf transferred the pharmacies to Siddiqui without MSI’s permission, and Siddiqui and his two corporations, Loch Raven Pharmacy and Bel-vedere Enterprises, began operating the pharmacies. Despite the transfer of the pharmacies, Yousuf continued to work as Siddiqui’s employee.

In April 2010, as a result of these events, MSI filed this lawsuit against Sid-diqui. In November 2010, MSI filed an amended complaint adding as defendants the corporations controlled by Siddiqui, Loch Raven Pharmacy and Belvedere Enterprises. In an effort to resolve the litigation, the parties drafted a Settlement and Release Agreement (“Settlement Agreement”). The Settlement Agreement provided, in part, that Siddiqui and the corporations agreed “to convert the Pharmacies to Medicap Pharmacies, Inc. (“MPI”) franchises and to execute a Medi-cap Pharmacy Franchise Agreement for each of the Pharmacies,” with each agreement lasting for three years. J.A. 410.

The Settlement Agreement contained two provisions with certain condition precedent language. First, Paragraph 4.C of the Settlement Agreement provided:

[u]pon execution of this Agreement and all necessary documents to effectuate conversion of the Pharmacies to MPI franchisees, MSI, its affiliates, succes *133 sors and/or assigns will release, discharge and hold Siddiqui and the Companies, their affiliates, successors and/or assigns, harmless from each and every claim relating to the Dispute, whether known or unknown, that MSI may have against Siddiqui and the Companies as of the Effective Date.

1J.A. 411. Second, Paragraph 4.E stated, “[u]pon receipt of the executed franchise documents discussed above, MSI agrees to cause its claims within the Litigation to be dismissed with prejudice[.]” Id.

On or about June 17, 2011, Siddiqui signed the Settlement Agreement for himself and the corporations. On July 5, 2011, MSI signed the Settlement Agreement. However, after the execution of the Settlement Agreement, Siddiqui failed to sign the franchise documents, personal guaranties, documents relating to purchasing inventory from Cardinal Health, Inc., and other related documents.

On July 7, 2011, Siddiqui and Yousuf entered into two bills of sale purportedly transferring Siddiqui’s one hundred percent interest in the two corporations to Yousuf. Each bill of sale provided that:

[t]he Buyer expressly understands and acknowledges that the liabilities associated with the said corporation^] ... including the personal guarantees provided by the Seller on such liabilities shall be discharged fully and completely by the buyer prior to the execution of this Bill of Sale.

J.A. 414-421. Yousuf did not discharge all liabilities fully and completely prior to the execution of each bill of sale. Additionally, MSI had no knowledge of these transactions.

On July 21, 2011, Appellees’ counsel informed MSI’s counsel that Siddiqui had died. On July 26, 2011, Appellees’ counsel e-mailed and faxed to MSI the signature pages of some of the franchise documents and personal guaranties. Yousuf had executed the documents on behalf of Loch Raven Pharmacy and Belvedere Enterprises as “President” of the corporations.

On July 27, 2011, the parties filed a Joint Status Report with the district court. The parties reported that Siddiqui “died sometime after signing a settlement agreement but before executing other documents necessary to carry out the terms of the settlement. The parties now disagree over the status of this matter.” J.A. 389. In light of the joint status report, the district court ordered the parties to conduct discovery regarding two issues: (1) the ownership of the corporations and the assets of Siddiqui’s estate and (2) the enforceability of the Settlement Agreement signed by Siddiqui shortly before his death.

On October 13, 2011, the district court held a status hearing and subsequently referred the matter to a United States Magistrate Judge to conduct a settlement conference. The parties’ negotiations with the magistrate judge were unsuccessful in resolving the case. Therefore, on April 18, 2012, the district court ordered the parties to submit briefs on whether or not the executed Settlement Agreement resolved the case and set a hearing in the matter.

On May 29, 2012, the district court held a hearing addressing the question of whether a settlement existed in the case. At this hearing, the court held the Settlement Agreement resulted in a full and effective settlement that resolved the dispute. Subsequently, in a two-page order, the district court found the Settlement Agreement to be valid and enforceable.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
549 F. App'x 131, Counsel Stack Legal Research, https://law.counselstack.com/opinion/medicine-shoppe-international-incorporated-v-mohammed-siddiqui-ca4-2013.